UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011411
Receipt No. R000013360
Scientific Title Phase II study of Erlotinib monotherapy in EGFR mutation-negative lung adenocarcinoma excluded biomarkers against EGFR-TKI treatment.
Date of disclosure of the study information 2013/08/07
Last modified on 2017/08/10 16:46:00

No. Disposal Last modified on Item of update
1 Insert 2013/08/07 19:43:30
2 Update 2014/08/08 14:33:41 Email
Last name of contact person
Last name of contact person
Address
Address
Email
3 Update 2017/08/10 16:46:00 Name of primary sponsor
Organization


Contact us.